Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014
- PMID: 28557757
- PMCID: PMC5728382
- DOI: 10.1542/peds.2016-4244
Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014
Abstract
Background and objectives: Surveillance for laboratory-confirmed influenza-associated pediatric deaths since 2004 has shown that most deaths occur in unvaccinated children. We assessed whether influenza vaccination reduced the risk of influenza-associated death in children and adolescents.
Methods: We conducted a case-cohort analysis comparing vaccination uptake among laboratory-confirmed influenza-associated pediatric deaths with estimated vaccination coverage among pediatric cohorts in the United States. Case vaccination and high-risk status were determined by case investigation. Influenza vaccination coverage estimates were obtained from national survey data or a national insurance claims database. We estimated odds ratios from logistic regression comparing odds of vaccination among cases with odds of vaccination in comparison cohorts. We used Bayesian methods to compute 95% credible intervals (CIs) for vaccine effectiveness (VE), calculated as (1 - odds ratio) × 100.
Results: From July 2010 through June 2014, 358 laboratory-confirmed influenza-associated pediatric deaths were reported among children aged 6 months through 17 years. Vaccination status was determined for 291 deaths; 75 (26%) received vaccine before illness onset. Average vaccination coverage in survey cohorts was 48%. Overall VE against death was 65% (95% CI, 54% to 74%). Among 153 deaths in children with underlying high-risk medical conditions, 47 (31%) were vaccinated. VE among children with high-risk conditions was 51% (95% CI, 31% to 67%), compared with 65% (95% CI, 47% to 78%) among children without high-risk conditions.
Conclusions: Influenza vaccination was associated with reduced risk of laboratory-confirmed influenza-associated pediatric death. Increasing influenza vaccination could prevent influenza-associated deaths among children and adolescents.
Copyright © 2017 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
Figures
Similar articles
-
Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016.J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):75-82. doi: 10.1093/jpids/piaa017. J Pediatric Infect Dis Soc. 2021. PMID: 32108879
-
The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.Vaccine. 2015 Dec 16;33(51):7239-7244. doi: 10.1016/j.vaccine.2015.10.122. Epub 2015 Nov 6. Vaccine. 2015. PMID: 26549359
-
Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.JAMA Netw Open. 2018 Oct 5;1(6):e183742. doi: 10.1001/jamanetworkopen.2018.3742. JAMA Netw Open. 2018. PMID: 30646262 Free PMC article.
-
Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study – exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine.Southampton (UK): NIHR Journals Library; 2013 Nov. Southampton (UK): NIHR Journals Library; 2013 Nov. PMID: 25642510 Free Books & Documents. Review.
-
Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis.Vaccine. 2020 Mar 23;38(14):2893-2903. doi: 10.1016/j.vaccine.2020.02.049. Epub 2020 Feb 27. Vaccine. 2020. PMID: 32113808 Review.
Cited by
-
Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in China.Clinics (Sao Paulo). 2024 Aug 2;79:100475. doi: 10.1016/j.clinsp.2024.100475. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 39096859 Free PMC article.
-
Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles.Front Immunol. 2024 Jun 10;15:1425842. doi: 10.3389/fimmu.2024.1425842. eCollection 2024. Front Immunol. 2024. PMID: 38915410 Free PMC article.
-
Optimal timing of influenza vaccination in young children: population based cohort study.BMJ. 2024 Feb 21;384:e077076. doi: 10.1136/bmj-2023-077076. BMJ. 2024. PMID: 38383038 Free PMC article.
-
[Efficacy and safety of pediatric flu vaccination: a systematic review].Rev Esp Quimioter. 2024 Feb;37(1):43-51. doi: 10.37201/req/101.2023. Epub 2023 Dec 5. Rev Esp Quimioter. 2024. PMID: 38050694 Free PMC article. Spanish.
-
Phylogenetic identification of influenza virus candidates for seasonal vaccines.Sci Adv. 2023 Nov 3;9(44):eabp9185. doi: 10.1126/sciadv.abp9185. Epub 2023 Nov 3. Sci Adv. 2023. PMID: 37922357 Free PMC article.
References
-
- Grohskopf L, Sokolow L, Broder K. Prevention and Control of Seasonal Influenza with Vaccines. MMWR Recomm Rep. 2016;65(RR-5):1–54. - PubMed
-
- Centers for Disease Control and Prevention. Influenza Associated Pediatric Mortality. Available at http://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html. Published 2016. Accessed November 9, 2016.
-
- Thompson M, Shay D, Zhou H, Bridges C, Cheng P, Burns E, et al. Updated Estimates of Mortality Associated with Seasonal Influenza through the 2006-2007 Influenza Season. MMWR. 2010;59(33):1057–1062. - PubMed
-
- Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006;194(Suppl 2):S82–91. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
